Enhanced Notch1 activity in hematopoietic stem/progenitor cells leads toT-ALL-like disease in mice, while genetic loss of function or the use of pharmacologicalNotch signaling inhibitors, such as γ-secretase inhibitors (GSIs), sensitizeT-ALL cells to glucocorticoid treatment. Here, NOTCH1 is linked to acute lymphoblastic leukemia.